NuCana (NCNA) Accounts Payables (2016 - 2025)

NuCana (NCNA) reported Accounts Payables of $694346.8 for Q4 2025, down 80.0% on a YoY basis from $3.5 million in Q4 2024, and down 69.04% sequentially from $2.2 million in Q3 2025.

NuCana (NCNA) Accounts Payables (2016 - 2025) Analysis & Trends

NuCana (NCNA) has 10 years of Accounts Payables data on file, last reported at $694346.8 in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 80.0% year-over-year to $694346.8; the trailing twelve-month figure through Dec 2025 stood at $694346.8 (down 80.0% YoY), and the FY2025 full-year result was $688262.4, down 80.09% from the prior year.
  • Accounts Payables fell to $694346.8 in Q4 2025, from $2.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $7.9 million in Q3 2024 to a low of $694346.8 in Q4 2025.
  • A 5-year average of $4.5 million and a median of $4.5 million in 2021 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables jumped 128.5% in 2022 and plunged 81.0% in 2025, its largest moves.
  • Tracing NCNA's Accounts Payables over 5 years: stood at $2.5 million in 2021, then jumped by 128.5% to $5.6 million in 2022, then slipped by 25.64% to $4.2 million in 2023, then declined by 17.12% to $3.5 million in 2024, then tumbled by 80.0% to $694346.8 in 2025.
  • Business Quant data shows NCNA's Accounts Payables at $694346.8 in Q4 2025, $2.2 million in Q3 2025, and $1.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 126.63 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 694,346.76
Sep 30, 2025 2.24 Mn
Jun 30, 2025 1.46 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 3.47 Mn
Sep 30, 2024 7.85 Mn
Jun 30, 2024 7.71 Mn
Mar 31, 2024 7.31 Mn
Dec 31, 2023 4.19 Mn
Sep 30, 2023 6.55 Mn
Jun 30, 2023 5.86 Mn
Mar 31, 2023 6.92 Mn
Dec 31, 2022 5.63 Mn
Sep 30, 2022 6.62 Mn
Jun 30, 2022 2.70 Mn
Mar 31, 2022 3.62 Mn
Dec 31, 2021 2.47 Mn
Sep 30, 2021 5.36 Mn
Jun 30, 2021 2.37 Mn
Mar 31, 2021 4.88 Mn